DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

Prothena Corporation (NASDAQ: PRTA)

22.97 1.46 (6.79%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PRTA $22.97 6.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $21.56
Previous Close $21.51
Daily Range $21.00 - $22.98
52-Week Range $16.71 - $49.24
Market Cap $629.0M
P/E Ratio 12.43
Dividend (Yield) $0.00 (0.0%)
Volume 287,018
Average Daily Volume 236,187
Current FY EPS -$0.44

Sector

Industry

Prothena Corporation (PRTA) Description

Prothena Corporation plc - Ordinary Shares Website: http://www.prothena.com/

News & Commentary

3 Stocks Poised for Eye-Popping Gains in 2015

Gilead Sciences, Orexigen Therapeutics, and Prothena Corp. are all poised to have a huge 2015. Here's what investors need to know.

Prothena Corp. (PRTA) Looks Good: Stock Moves Up 5.7% - Tale of the Tape

Health Care Sector Update for 12/16/2014: PRTA,NVGN,CYCC

UPDATE: Prothena Receives FDA Fast Track Designation for NEOD001

Commit To Purchase Prothena Corp At $17.50, Earn 33.1% Annualized Using Options

Prothena Corporation (PRTA) Falls: Stock Goes Down 5% - Tale of the Tape

Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based On Positive Results In Ongoing

Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based On Positive Results In Ongoing Phase 1/2 Study of NEOD001 In Patients With AL Amyloidosis

Prothena Reports Initiation of NEOD001 Global Phase 3 Registrational Trial Based on Positive Results

Prothena Reports Initiation of NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study

Why You Shouldn't Bet Against Prothena Corporation (PRTA) Stock - Tale of the Tape

Prothena's Management Presents at 2014 Credit Suisse Healthcare Conference (Transcript)

See More PRTA News...